Livzon Pharmaceutical details extensive A-share repurchases

Livzon Pharmaceutical Group reported its latest next day disclosure on November 4, 2025, detailing numerous A-share repurchases between December 25, 2024, and November 4, 2025. The repurchases, executed on the Shenzhen Stock Exchange, involved a total of 164,700 A-shares on November 4, 2025, at prices ranging from RMB 36.16 to RMB 36.71. This amounted to a total cost of RMB 5,999,819 for that day.

The company's outstanding H-shares remained unchanged at 299,807,117 as of November 4, 2025. The disclosure highlights a consistent pattern of share buybacks, with individual daily repurchases varying from 1,700 to 561,400 A-shares. The prices paid for these repurchases fluctuated, generally ranging from RMB 34 to RMB 41.99 per share across the disclosed period.

As of November 4, 2025, the total number of A-shares repurchased and pending cancellation stood at 164,700, with no shares held as treasury stock.